TCW Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Buy
2,679
+129
+5% +$64.9K 0.01% 329
2025
Q4
$1.19M Buy
+2,550
New +$1.18M 0.01% 337
2017
Q1
Sell
-21,637
Closed -$1.6M 485
2016
Q4
$1.6M Sell
21,637
-163
-0.7% -$12.2K 0.01% 399
2016
Q3
$1.65M Sell
21,800
-300
-1% -$23K 0.01% 376
2016
Q2
$1.7M Buy
22,100
+700
+3% +$55.3K 0.01% 363
2016
Q1
$1.67M Sell
21,400
-350
-2% -$24.4K 0.01% 382
2015
Q4
$1.47M Sell
21,750
-150
-0.7% -$10.5K 0.01% 419
2015
Q3
$1.69M Buy
21,900
+2,500
+13% +$221K 0.01% 392
2015
Q2
$1.76M Sell
19,400
-63,600
-77% -$5.1M 0.01% 419
2015
Q1
$6.24M Buy
+83,000
New +$5.96M 0.03% 344

Other funds holding HCA

TCW Group's HCA Position: Q1 2026 in Review

TCW Group increased its HCA Healthcare (HCA) stake by 5.1% in Q1 2026, buying an estimated $64.9K and bringing the position to 2,679 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #329.

TCW Group first reported a position in HCA in Q1 2015 and has held it in 10 quarters since. The position peaked at $6.24M in Q1 2015. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • TCW Group held 2,679 shares of HCA Healthcare worth $1.27M as of Q1 2026.
  • TCW Group bought 129 HCA Healthcare shares in Q1 2026, an estimated $64.9K.
  • HCA Healthcare made up 0.01% of TCW Group's portfolio in Q1 2026, its #329 holding.
  • TCW Group first reported a position in HCA Healthcare in Q1 2015 and has held it in 10 quarters since.
  • TCW Group's HCA Healthcare position peaked at $6.24M in Q1 2015.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.